Measuring inconsistency in meta-analyses

British Medical Journal

Volumn 327, Issue 7414, 2003, Pages 557-560

  Higgins, Julian P T ^a   Thompson, Simon G ^a   Deeks, Jonathan J ^b   Altman, Douglas G ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; MAGNESIUM; SEROTONIN UPTAKE INHIBITOR; STREPTOKINASE; TAMOXIFEN;

BREAST CANCER; CLINICAL TRIAL; DEPRESSION; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HEART INFARCTION; HUMAN; INFLUENZA; MEDICAL LITERATURE; MEDICAL RESEARCH; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

DATA INTERPRETATION, STATISTICAL; META-ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0041876133     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7414.557     Document Type: Review

References (24)

1. Egger M, Davey Smith G. Meta-analysis: potentials and promise. BMJ 1997;315:1371-4.
2. Liberati A, Buzzetti R, Grilli R, Magrini N, Minozzi S. Which guidelines can we trust? West J Med 2001;174:262-5.
3. Harbour R, Miller J for the Scottish Intercollegiate Guidelines Network Grading Review Group. A new system for grading recommendations in evidence based guidelines. BMJ 2001;323:334-6.
4. Guyatt G, Sinclair J, Cook D, Jaeschke R, Schünemann H, Pauker S. Moving from evidence to action. In: Guyatt G, Rennie D, eds. Users' guides to the medical literature: a manual for evidence-based clinical practice. Chicago: American Medical Association, 2002:599-608.
5. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med 2001;20:3625-33.
6. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002;7:51-61.
7. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-29.
8. Sterne JAC, Egger M. Funnel plots for detecting bias th meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001;54:1046-55.
9. Paul SR, Donner A. Small sample performance of tests of homogeneity of odds ratios in k 2x2 tables. Stat Med 1992;11:159-65.
10. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998;17:841-56.
11. Jefferson TO, Demicheli V, Deeks JJ, Rivetti D. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev 2002;(4):CD001169.
12. Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev 1992;14:154-76.
13. Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, et al. Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev 2003;(3):CD002791.
14. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
15. Sterne JAC, Bradburn MJ, Egger M. Meta-analysis in STATA. In: Egger M, Davey Smith G, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publications, 2001:347-69.
16. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randontised trials. Lancet 1998;351:1451-67.
17. Lau J, Antman EM, Jimenez-Silva J, Kupelink B, Mosteller SF, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.
18. Egger M, Davey Smith G. Misleading meta-analysis. BMJ 1995;310:752-4.
19. Angelillo IF, Villari P. Residential exposure to electromagnetic fields and childhood leukaemia: a meta-analysis. Bull World Health Organ 1999;77:906-15.
20. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998;317:235-40.
21. Engels EA, Schmid CH, Terrin N, Olkin I, Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 2000;19:1707-28.
22. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 2002;21;1575-1600.
23. Freeman PR. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Stat Med 1989;8:1421-32.
24. Steyerberg EW, Eijkemans MJ, Habbema JD. Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999;52:935-42.